Transitioning to People-Centred Antimicrobial Resistance Surveillance

This review argues that antimicrobial resistance (AMR) surveillance systems should prioritize their role in improving patient care rather than serving solely as data inputs for global monitoring. The authors highlight how blood culture–based AMR surveillance can fail to support local clinical decision-making if not optimized as a diagnostic tool. Strengthening local capacity to use and act on surveillance data can improve patient outcomes while enhancing the sustainability and effectiveness of global AMR monitoring efforts.